SPHTM Responds to Ebola: The Hemorrhagic Fevers Expert: Daniel Bausch, MD

Daniel Bausch

Daniel Bausch

Infectious disease specialist and associate professor of tropical medicine Dan Bausch was among the researchers who first noted a new appearance of Ebola in Guinea in March 2014. As a member of the Viral Hemorrhagic Fever Consortium and Tulane’s point person for the WHO’s Global Outbreak and Response Network (GOARN), as well as head of the Virology and Emerging Infections Department for the U.S. Naval Medical Research Unit No.6 in Lima, Peru, Bausch was in Sierra Leone during June and July. At one point he was one of two doctors caring for a ward populated with 60 Ebola patients.

He has since spent much of the time traveling the world, advocating for international bodies to close the gaps in Ebola response and speed up the development of Ebola treatments. In late September and October he worked with the CDC to train clinicians who would be working on the Ebola response.

He’s become a reluctant media star in addition to an international advocate, often highlighting the importance of funding, protocol, international collaboration, and resources, including the provision of supplies to make home-based care safer and pharmaceutical investment in drug development.

“The vaccines and treatments that we have for this are experimental, but we want to try to push those through and get the testing that they need to have real world products to help people in West Africa,” he says, emphasizing that safety is important but so is the principle of compassionate care. Addressing the outbreak will take a global effort on multiple fronts, he often emphasizes. “It’s not a sprint, it’s a marathon,” he says.

Like all dedicated marathoners, these Tulanians and others on the front lines occasionally take stock, rest a moment, and then get back into the race, bringing the full force of public health and medical training to bear.

“If it was an Ebola outbreak someplace else, I would put in my time, of course, but this is Ebola coming to us, it’s our home,” says Moses speaking of Sierra Leone. “So I want to head back.”

EBOLA BY THE NUMBERS
13,268 Ebola cases worldwide
4,960 deaths attributed to Ebola
8 countries have reported cases since the outbreak began
Data secured from the Ebola Response Roadmap Situation Response from the World Health Organization, dated November 7, 2014.

Continued: The Airport Screener: Wes McDermott

Advertisements

About Tulane University SPHTM

Tulane's School of Public Health and Tropical Medicine is the oldest school of public health in the country and the only American school of tropical medicine. Our mission is to advance public health knowledge, promote health and well-being, and prevent disease, disability, and premature mortality. This is accomplished through academic excellence in education of public health professionals, rigorous scientific research of public health problems, creative partnerships to advance the practice of public health, and innovative service to the local, national, and international public health community.
This entry was posted in Fall/Winter 2014. Bookmark the permalink.

One Response to SPHTM Responds to Ebola: The Hemorrhagic Fevers Expert: Daniel Bausch, MD

  1. Pingback: SPHTM Responds to Ebola: The Biologist: Lisa Guerrero, MPH | Global Health Spring/Summer 2014

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s